tiprankstipranks
Advertisement
Advertisement
Janux Therapeutics price target lowered to $36 from $45 at Wedbush
PremiumThe FlyJanux Therapeutics price target lowered to $36 from $45 at Wedbush
3M ago
Janux Therapeutics price target lowered to $26 from $30 at Piper Sandler
Premium
The Fly
Janux Therapeutics price target lowered to $26 from $30 at Piper Sandler
3M ago
Analyst Reiterates Buy on Janux Therapeutics, Citing Deep Pipeline Catalysts and Compelling Risk/Reward at Near-Zero Enterprise Value
Premium
Ratings
Analyst Reiterates Buy on Janux Therapeutics, Citing Deep Pipeline Catalysts and Compelling Risk/Reward at Near-Zero Enterprise Value
3M ago
Janux Therapeutics Adjusts Board Class Structure for Director
PremiumCompany AnnouncementsJanux Therapeutics Adjusts Board Class Structure for Director
4M ago
Janux Therapeutics price target lowered to $28 from $50 at JonesResearch
Premium
The Fly
Janux Therapeutics price target lowered to $28 from $50 at JonesResearch
4M ago
Janux Therapeutics announces discontinuation of JANX008 clinical development
Premium
The Fly
Janux Therapeutics announces discontinuation of JANX008 clinical development
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100